Skip to content
Solesence, Inc. Common Stock logo

Solesence, Inc. Common Stock

SLSN

Solesence, Inc. is a scientifically driven health care innovator that develops and manufactures skin health products across the beauty, health, and wellness categories.

Market cap
$49.18M-81.2%
Revenue$60.4M+5.8%
Net income$944.0K-80.6%
Free cash flow-$11.1M-34.7%
EPS (diluted)$0.01-80.0%
Trailing twelve months · change vs. prior year

Earnings

Next report

Aug 6, 2026 (In 3 weeks)

Financials

Q1 2026

Income statement

See full
Revenue$13.0M-11.4%
Gross profit$3.3M-1.3%
Operating income-$504.0K-297%
Net income-$766.0K-1,058%
EPS (diluted)-$0.01

Balance sheet

See full
Cash & equivalents$573.0K-68.5%
Total debt$9.7M-3.3%
Total equity$17.0M+11.9%
Total assets$47.8M-16.2%

Cash flow

See full
Operating cash flow$1.5M+121%
CapEx$528.0K+497%
Free cash flow$989.0K+113%

Valuation & ratios

Valuation

See full
Market cap$49.18M-81.2%
Enterprise value$58.34M-77.9%
P/E52.1×
P/S0.8×-3.2×

Profitability

See full
Gross margin26.5%-1.5pp
Operating margin1.3%-6.5pp
Net margin1.6%

Returns & leverage

See full
Return on equity5.9%
Debt / equity0.6×-0.1×
Current ratio2.1×+1.0×

Segments

By product

See full
Consumer Products$10.0M-22.2%
Personal Care Ingredients$2.7M+98.5%
Advanced Materials$205.0K-44.6%

By geography

See full
Non Us$913.0K-8.1%

Competitors

Profile

Solesence, Inc. is a scientifically driven health care innovator that develops and manufactures skin health products across the beauty, health, and wellness categories. The company leverages a proprietary technology platform to create mineral-based sunscreens, skin care, and color cosmetics that protect against environmental aggressors like UV rays and pollution. Its core value proposition lies in the vertical integration of materials engineering and formulation expertise to deliver high-performance finished products for global prestige and mass-market brands.

Competitive position

The company holds a leading position in mineral-based UV protection through its vertically integrated model that combines patented material science with finished product formulation.

GeographiesUnited States, Canada, Australia, Europe, China, Korea
Customer segmentsPrestige Beauty, Health and Wellness, Pharmaceutical
Business modelContract Manufacturing, B2B, White Label, IP Licensing
SuppliersHigh purity zinc suppliers, Chemical processors, Raw material suppliers from China and Korea
CustomersPrestige beauty brands, Omnichannel retail brands, Global chemical distributors, Consumer product manufacturers
Listed1997
Employees98.0
CEOKevin Cureton
FilingsSEC EDGAR

Questions, answered.

What is Solesence, Inc. Common Stock's market cap?
Solesence, Inc. Common Stock (SLSN) has a market capitalization of $49.2M and trades on NASDAQ.
What is Solesence, Inc. Common Stock's revenue and profitability?
Solesence, Inc. Common Stock generated $60.4M in trailing twelve-month revenue with net income of $944.0K, representing a net margin of 1.6%. Gross margin stands at 26.5%, with free cash flow of -$11.1M. These figures are based on the Q1 2026 filing.
Who are Solesence, Inc. Common Stock's competitors?
Solesence, Inc. Common Stock's key competitors include Colgate-Palmolive Company, Ashland Inc., The Beauty Health Company Class A Common Stock, and others. These companies compete in similar markets and product categories.
Who does Solesence, Inc. Common Stock partner with?
Solesence, Inc. Common Stock's notable partners include BASF Corporation.
What subsidiaries does Solesence, Inc. Common Stock have?
Solesence, Inc. Common Stock's subsidiaries include Solésence, LLC.
Where is Solesence, Inc. Common Stock headquartered?
Solesence, Inc. Common Stock is headquartered in United States of America and employs approximately 98 people. It has been publicly traded since 1997.